Tracking cystic fibrosis with mice

Cystic fibrosis, also known as mucoviscidosis, is one of the most common genetic diseases with a fatal outcome in western Europe. The disease is caused by a defective gene that affects the salt and fluid composition of respiratory tract secretions. As a result, they become highly viscous. The viscous mucous then clumps in the smaller lung passages. Previously, it was not understood how the defective gene causes these changes. Studies of animal models with the same genetic defect, e.g., mice, frequently result in an improved understanding of the origins of a disease. This had not been possible for cystic fibrosis because the equivalent genetic defect did not cause lung disease in mice.

Marcus Mall, a medical researcher, genetically modified mice to generate the typical symptoms of cystic fibrosis. As a result, he was able to demonstrate for the first time the long suspected relationship between the genetic defect, salt transport to the respiratory tract surface and the genesis of the lung disease in a living organism. The origin of the disease and, possibly, types of therapy for humans can also be studied with these genetically modified mice.

To study the effect of the defective "cystic fibrosis transmembrane conductance regulator" gene (CFTR), Mall's group focussed on certain ion channels. These channels transport sodium ions through the cell membrane and thus regulate the fluid content of the cells. The altered fluid content of the mucous film that "lubricates" the respiratory tract causes clumping of the mucous so that natural removal of dust and bacteria from the respiratory tract is no longer possible. Mice, whose sodium ion channels had been altered, became ill with the lung inflammation typical of cystic fibrosis. The researchers demonstrated with a high degree of probability the direct link between the ion transport disorder and cystic fibrosis.

The genetically modified mice will be used by the researchers for further studies. The mice

Contact: Dr. Marcus Mall
Deutsche Forschungsgemeinschaft

Page: 1 2

Related biology news :

1. Tracking climate change
2. Tracking the illegal ivory trade
3. Tracking every egg? AAAS report lists practical options for regulating human cloning
4. School of public health launches CDC Center for Excellence in Environmental Public Health Tracking
5. Satellites vs. mosquitoes: Tracking West Nile Virus in the U.S.
6. Tracking and treating toxic waste in urban neighborhoods
7. Tracking path of virulent bacteria via the web
8. Tracking a genetic basis for alcohol-related hypertension
9. Fat In Spite Of Hard Farm Work - Tracking Down Obesity
10. Tracking A Legacy Of Waste In The West Siberian Basin
11. International Expert To Discuss Ramifications At Local Lecture...Tracking Contaminants In The Mighty Mississippi And Other Large Rivers Worldwide

Post Your Comments:

(Date:7/18/2020)... ... 2020 , ... A study has been published in the ... noise control device to attenuate typical noises in a simulated neonatal intensive care ... sounds from patient monitors, ventilators and other bedside devices that would affect the ...
(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues in Regenerative ... Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy ... effective way to complete one? Will the study comply with all FDA requirements? ...
(Date:7/4/2020)... ... 03, 2020 , ... Aesthetics Biomedical (ABM), a leading aesthetics ... not only the products and treatments developed, but also the dedicated team behind ... the brands built by ABM have received several honors already for 2020, each ...
Breaking Biology News(10 mins):
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech , ... Solutions, in a one hour live webinar on Thursday, August 13, 2020 ... for drugs and medical devices. Specifically, for medical devices, the NMPA has departments dealing ...
(Date:7/18/2020)... Ohio (PRWEB) , ... July 16, 2020 , ... ... data solutions to aid in the early detection and prevention of high-burden diseases, ... to enable US-based hospitals and healthcare organizations to utilize existing data in order ...
(Date:7/10/2020)... , ... July 09, 2020 ... ... company, announced today that Massachusetts Institute of Technology (MIT) has expanded the ... license allows PathSensors to move into the point-of-care diagnostic market, focusing initially ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now ... up to 200 million stem cells. Depending on the patient's condition, treatment may be ... US will die having some form of Alzheimers dementia, and the incidence continues to ...
Breaking Biology Technology:
Cached News: